| Trait Information | |
| Identifier | MONDO_0004867 |
| Description | A disease involving the upper respiratory tract. | Trait category |
Other trait
|
| Synonyms |
5 synonyms
|
| Child trait(s) | 11 child traits |
| Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
|---|---|---|---|---|---|---|
| PGS000360 (PRSWEB_PHECODE149.4_C32_LASSOSUM_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Laryngeal cancer | larynx cancer | 25,920 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000360/ScoringFiles/PGS000360.txt.gz | |
| PGS000361 (PRSWEB_PHECODE149.4_C3-LARYNX_LASSOSUM_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Laryngeal cancer | larynx cancer | 87,893 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000361/ScoringFiles/PGS000361.txt.gz | |
| PGS000362 (PRSWEB_PHECODE149.4_UKBB-SAIGE-HRC-X149.4_PT_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Laryngeal cancer | larynx cancer | 53 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000362/ScoringFiles/PGS000362.txt.gz | |
| PGS000388 (PRSWEB_PHECODE165.1_C3-BRONCHUS-LUNG_PRS-CS_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Lung and bronchus cancer | tracheal cancer, bronchus cancer, lung cancer |
1,109,069 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000388/ScoringFiles/PGS000388.txt.gz | |
| PGS000389 (PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_P_5e-08_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Lung and bronchus cancer | tracheal cancer, bronchus cancer, lung cancer |
21 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000389/ScoringFiles/PGS000389.txt.gz | |
| PGS000390 (PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_P_5e-08_UKB_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Lung and bronchus cancer | tracheal cancer, bronchus cancer, lung cancer |
21 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000390/ScoringFiles/PGS000390.txt.gz | |
| PGS000391 (PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_PT_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Lung and bronchus cancer | tracheal cancer, bronchus cancer, lung cancer |
14 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000391/ScoringFiles/PGS000391.txt.gz | |
| PGS000392 (PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_PT_UKB_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Lung and bronchus cancer | tracheal cancer, bronchus cancer, lung cancer |
19 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000392/ScoringFiles/PGS000392.txt.gz | |
| PGS000393 (PRSWEB_PHECODE165.1_LUNG-CANCER_PRS-CS_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Lung and bronchus cancer | tracheal cancer, bronchus cancer, lung cancer |
1,110,438 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000393/ScoringFiles/PGS000393.txt.gz | |
| PGS000394 (PRSWEB_PHECODE165.1_LUNG-CANCER-MESOT_PRS-CS_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Lung and bronchus cancer | tracheal cancer, bronchus cancer, lung cancer |
1,110,438 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000394/ScoringFiles/PGS000394.txt.gz | |
| PGS000395 (PRSWEB_PHECODE165.1_UKBB-SAIGE-HRC-X165.1_PRS-CS_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Lung and bronchus cancer | tracheal cancer, bronchus cancer, lung cancer |
1,119,238 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000395/ScoringFiles/PGS000395.txt.gz | |
| PGS000396 (PRSWEB_PHECODE165.1_UKBB-SAIGE-HRC-X165.1_PT_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Lung and bronchus cancer | tracheal cancer, bronchus cancer, lung cancer |
75 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000396/ScoringFiles/PGS000396.txt.gz | |
| PGS000397 (PRSWEB_PHECODE165.1_UKBB-SAIGE-HRC-X165.1_LASSOSUM_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Lung and bronchus cancer | tracheal cancer, bronchus cancer, lung cancer |
46,920 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000397/ScoringFiles/PGS000397.txt.gz | |
| PGS001109 (GBE_HC1021) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Vasomotor and allergic rhinitis (time-to-event) | vasomotor rhinitis, allergic rhinitis |
1,910 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001109/ScoringFiles/PGS001109.txt.gz |
| PGS001259 (GBE_HC49) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Hayfever/allergic rhinitis | seasonal allergic rhinitis | 349 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001259/ScoringFiles/PGS001259.txt.gz |
| PGS001326 (GBE_HC431) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Emphysema | pulmonary emphysema | 42 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001326/ScoringFiles/PGS001326.txt.gz |
| PGS001332 (GBE_HC442) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Chronic obstructive pulmonary disease | chronic obstructive pulmonary disease | 482 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001332/ScoringFiles/PGS001332.txt.gz |
| PGS001333 (GBE_HC1582) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Chronic obstructive pulmonary disease (algorithmically-defined) | chronic obstructive pulmonary disease | 569 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001333/ScoringFiles/PGS001333.txt.gz |
| PGS001334 (GBE_HC1035) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Other chronic obstructive pulmonary disease (time-to-event) | chronic obstructive pulmonary disease | 498 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001334/ScoringFiles/PGS001334.txt.gz |
| PGS001783 (1kgeur_gbmi_COPD_pst_eff_a1_b0.5_phiauto) |
PGP000262 | Wang Y et al. Cell Genom (2023) |
Chronic obstructive pulmonary disease | chronic obstructive pulmonary disease | 884,139 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001783/ScoringFiles/PGS001783.txt.gz |
| PGS001788 (1kgeur_gbmi_leaveUKBBout_COPD_pst_eff_a1_b0.5_phiauto) |
PGP000262 | Wang Y et al. Cell Genom (2023) |
Chronic obstructive pulmonary disease | chronic obstructive pulmonary disease | 910,082 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001788/ScoringFiles/PGS001788.txt.gz |
| PGS001850 (portability-PLR_496) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Chronic airway obstruction | chronic obstructive pulmonary disease | 7,347 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001850/ScoringFiles/PGS001850.txt.gz |
| PGS002062 (portability-ldpred2_496) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Chronic airway obstruction | chronic obstructive pulmonary disease | 811,003 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002062/ScoringFiles/PGS002062.txt.gz |
| PGS002291 (PRS12_NPC) |
PGP000320 | He YQ et al. Nat Commun (2022) |
Nasopharyngeal carcinoma | nasopharyngeal neoplasm | 12 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002291/ScoringFiles/PGS002291.txt.gz |
| PGS004465 (disease.J33.score) |
PGP000561 | Jung H et al. Commun Biol (2024) |
J33 (Nasal polyp) | nasal cavity polyp | 1,059,939 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004465/ScoringFiles/PGS004465.txt.gz |
| PGS004466 (disease.J44.score) |
PGP000561 | Jung H et al. Commun Biol (2024) |
J44 (Other chronic obstructive pulmonary disease) | chronic obstructive pulmonary disease | 1,059,939 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004466/ScoringFiles/PGS004466.txt.gz |
| PGS004535 (meta.J33.score) |
PGP000561 | Jung H et al. Commun Biol (2024) |
J33 (Nasal polyp) | nasal cavity polyp | 1,059,939 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004535/ScoringFiles/PGS004535.txt.gz |
| PGS004536 (meta.J44.score) |
PGP000561 | Jung H et al. Commun Biol (2024) |
J44 (Other chronic obstructive pulmonary disease) | chronic obstructive pulmonary disease | 1,059,939 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004536/ScoringFiles/PGS004536.txt.gz |
| PGS012564 (GRS22_COPD) |
PGP000808 | Li J et al. BMC Med (2024) |
Chronic obstructive pulmonary disease | chronic obstructive pulmonary disease | 22 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS012564/ScoringFiles/PGS012564.txt.gz |
| PGS018465 (TPMI_149_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of larynx pharynx nasal cavities | larynx cancer | 4 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018465/ScoringFiles/PGS018465.txt.gz | |
| PGS018466 (TPMI_149_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of larynx pharynx nasal cavities | larynx cancer | 939,820 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018466/ScoringFiles/PGS018466.txt.gz | |
| PGS018467 (TPMI_149_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of larynx pharynx nasal cavities | larynx cancer | 15,690 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018467/ScoringFiles/PGS018467.txt.gz | |
| PGS018468 (TPMI_149_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of larynx pharynx nasal cavities | larynx cancer | 983,777 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018468/ScoringFiles/PGS018468.txt.gz | |
| PGS018469 (TPMI_149_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of larynx pharynx nasal cavities | larynx cancer | 1,000,712 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018469/ScoringFiles/PGS018469.txt.gz | |
| PGS018470 (TPMI_149.2_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of nasopharynx | malignant tumor of nasopharynx | 211 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018470/ScoringFiles/PGS018470.txt.gz | |
| PGS018471 (TPMI_149.2_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of nasopharynx | malignant tumor of nasopharynx | 45,670 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018471/ScoringFiles/PGS018471.txt.gz | |
| PGS018472 (TPMI_149.2_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of nasopharynx | malignant tumor of nasopharynx | 10,449 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018472/ScoringFiles/PGS018472.txt.gz | |
| PGS018473 (TPMI_149.2_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of nasopharynx | malignant tumor of nasopharynx | 983,776 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018473/ScoringFiles/PGS018473.txt.gz | |
| PGS018474 (TPMI_149.2_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of nasopharynx | malignant tumor of nasopharynx | 1,005,312 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018474/ScoringFiles/PGS018474.txt.gz | |
| PGS019265 (TPMI_472_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Chronic pharyngitis and nasopharyngitis | pharyngitis | 742,330 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS019265/ScoringFiles/PGS019265.txt.gz | |
| PGS019266 (TPMI_472_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Chronic pharyngitis and nasopharyngitis | pharyngitis | 939,806 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS019266/ScoringFiles/PGS019266.txt.gz | |
| PGS019267 (TPMI_472_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Chronic pharyngitis and nasopharyngitis | pharyngitis | 666,847 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS019267/ScoringFiles/PGS019267.txt.gz | |
| PGS019268 (TPMI_472_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Chronic pharyngitis and nasopharyngitis | pharyngitis | 983,764 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS019268/ScoringFiles/PGS019268.txt.gz | |
| PGS019269 (TPMI_472_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Chronic pharyngitis and nasopharyngitis | pharyngitis | 994,353 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS019269/ScoringFiles/PGS019269.txt.gz | |
| PGS019275 (TPMI_476_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Allergic rhinitis | allergic rhinitis | 243,320 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS019275/ScoringFiles/PGS019275.txt.gz | |
| PGS019276 (TPMI_476_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Allergic rhinitis | allergic rhinitis | 939,881 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS019276/ScoringFiles/PGS019276.txt.gz | |
| PGS019277 (TPMI_476_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Allergic rhinitis | allergic rhinitis | 17,340 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS019277/ScoringFiles/PGS019277.txt.gz | |
| PGS019278 (TPMI_476_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Allergic rhinitis | allergic rhinitis | 983,820 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS019278/ScoringFiles/PGS019278.txt.gz | |
| PGS019279 (TPMI_476_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Allergic rhinitis | allergic rhinitis | 950,545 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS019279/ScoringFiles/PGS019279.txt.gz |
|
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|---|
| PPM001045 | PGS000360 (PRSWEB_PHECODE149.4_C32_LASSOSUM_MGI_20200608) |
PSS000536| European Ancestry| 1,738 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of larynx | OR: 1.282 [1.09, 1.508] β: 0.249 (0.0827) |
AUROC: 0.57 [0.522, 0.618] | Nagelkerke's Pseudo-R²: 0.0112 Brier score: 0.0822 Odds Ratio (OR, top 1% vs. Rest): 2.14 [0.649, 7.06] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE149.4_C32_LASSOSUM_MGI_20200608 |
| PPM001046 | PGS000361 (PRSWEB_PHECODE149.4_C3-LARYNX_LASSOSUM_MGI_20200608) |
PSS000536| European Ancestry| 1,738 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of larynx | OR: 1.195 [1.014, 1.408] β: 0.178 (0.0836) |
AUROC: 0.55 [0.504, 0.593] | Nagelkerke's Pseudo-R²: 0.00551 Brier score: 0.0824 Odds Ratio (OR, top 1% vs. Rest): 1.51 [0.382, 5.94] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE149.4_C3-LARYNX_LASSOSUM_MGI_20200608 |
| PPM001047 | PGS000362 (PRSWEB_PHECODE149.4_UKBB-SAIGE-HRC-X149.4_PT_MGI_20200608) |
PSS000536| European Ancestry| 1,738 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of larynx | OR: 1.195 [1.023, 1.396] β: 0.178 (0.0793) |
AUROC: 0.543 [0.494, 0.59] | Nagelkerke's Pseudo-R²: 0.00609 Brier score: 0.0824 Odds Ratio (OR, top 1% vs. Rest): 1.52 [0.384, 5.98] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE149.4_UKBB-SAIGE-HRC-X149.4_PT_MGI_20200608 |
| PPM001073 | PGS000388 (PRSWEB_PHECODE165.1_C3-BRONCHUS-LUNG_PRS-CS_MGI_20200608) |
PSS000541| European Ancestry| 4,698 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of bronchus; lung | OR: 1.132 [1.024, 1.25] β: 0.124 (0.0508) |
AUROC: 0.533 [0.505, 0.562] | Nagelkerke's Pseudo-R²: 0.00265 Brier score: 0.0827 Odds Ratio (OR, top 1% vs. Rest): 1.96 [0.926, 4.14] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_C3-BRONCHUS-LUNG_PRS-CS_MGI_20200608 |
| PPM001074 | PGS000389 (PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_P_5e-08_MGI_20200608) |
PSS000541| European Ancestry| 4,698 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of bronchus; lung | OR: 1.11 [1.006, 1.225] β: 0.105 (0.0501) |
AUROC: 0.52 [0.492, 0.547] | Nagelkerke's Pseudo-R²: 0.00202 Brier score: 0.0827 Odds Ratio (OR, top 1% vs. Rest): 2.19 [1.07, 4.49] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_P_5e-08_MGI_20200608 |
| PPM001075 | PGS000390 (PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_P_5e-08_UKB_20200608) |
PSS000566| European Ancestry| 12,201 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of bronchus; lung | OR: 1.194 [1.124, 1.269] β: 0.178 (0.0309) |
AUROC: 0.543 [0.526, 0.562] | Nagelkerke's Pseudo-R²: 0.00583 Brier score: 0.0824 Odds Ratio (OR, top 1% vs. Rest): 0.852 [0.437, 1.66] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_P_5e-08_UKB_20200608 |
| PPM001076 | PGS000391 (PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_PT_MGI_20200608) |
PSS000541| European Ancestry| 4,698 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of bronchus; lung | OR: 1.12 [1.015, 1.237] β: 0.114 (0.0507) |
AUROC: 0.529 [0.503, 0.558] | Nagelkerke's Pseudo-R²: 0.00234 Brier score: 0.0827 Odds Ratio (OR, top 1% vs. Rest): 1.75 [0.796, 3.85] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_PT_MGI_20200608 |
| PPM020287 | PGS000391 (PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_PT_MGI_20200608) |
PSS011324| European Ancestry| 1,202 individuals |
PGP000539 | Lebrett MB et al. Genet Med (2023) |Ext. |
Reported Trait: Lung cancer | — | AUROC: 0.731 [0.703, 0.759] | — | Age, sex, current smoking status, BMI, forced expiratory volume in 1 second/forced vital capacity ratio | — |
| PPM001077 | PGS000392 (PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_PT_UKB_20200608) |
PSS000566| European Ancestry| 12,201 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of bronchus; lung | OR: 1.221 [1.149, 1.298] β: 0.2 (0.0313) |
AUROC: 0.552 [0.534, 0.569] | Nagelkerke's Pseudo-R²: 0.00728 Brier score: 0.0824 Odds Ratio (OR, top 1% vs. Rest): 1.94 [1.22, 3.1] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_PT_UKB_20200608 |
| PPM020288 | PGS000392 (PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_PT_UKB_20200608) |
PSS011324| European Ancestry| 1,202 individuals |
PGP000539 | Lebrett MB et al. Genet Med (2023) |Ext. |
Reported Trait: Lung cancer | — | AUROC: 0.733 [0.705, 0.761] | — | Age, sex, current smoking status, BMI, forced expiratory volume in 1 second/forced vital capacity ratio | — |
| PPM001078 | PGS000393 (PRSWEB_PHECODE165.1_LUNG-CANCER_PRS-CS_MGI_20200608) |
PSS000541| European Ancestry| 4,698 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of bronchus; lung | OR: 1.149 [1.04, 1.269] β: 0.139 (0.0509) |
AUROC: 0.539 [0.508, 0.568] | Nagelkerke's Pseudo-R²: 0.00329 Brier score: 0.0826 Odds Ratio (OR, top 1% vs. Rest): 2.18 [1.06, 4.46] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_LUNG-CANCER_PRS-CS_MGI_20200608 |
| PPM001079 | PGS000394 (PRSWEB_PHECODE165.1_LUNG-CANCER-MESOT_PRS-CS_MGI_20200608) |
PSS000541| European Ancestry| 4,698 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of bronchus; lung | OR: 1.149 [1.04, 1.269] β: 0.139 (0.0509) |
AUROC: 0.539 [0.508, 0.568] | Nagelkerke's Pseudo-R²: 0.00329 Brier score: 0.0826 Odds Ratio (OR, top 1% vs. Rest): 2.18 [1.06, 4.46] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_LUNG-CANCER-MESOT_PRS-CS_MGI_20200608 |
| PPM001080 | PGS000395 (PRSWEB_PHECODE165.1_UKBB-SAIGE-HRC-X165.1_PRS-CS_MGI_20200608) |
PSS000541| European Ancestry| 4,698 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of bronchus; lung | OR: 1.133 [1.025, 1.252] β: 0.125 (0.051) |
AUROC: 0.533 [0.505, 0.562] | Nagelkerke's Pseudo-R²: 0.00277 Brier score: 0.0827 Odds Ratio (OR, top 1% vs. Rest): 1.27 [0.514, 3.12] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_UKBB-SAIGE-HRC-X165.1_PRS-CS_MGI_20200608 |
| PPM001081 | PGS000396 (PRSWEB_PHECODE165.1_UKBB-SAIGE-HRC-X165.1_PT_MGI_20200608) |
PSS000541| European Ancestry| 4,698 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of bronchus; lung | OR: 1.121 [1.015, 1.238] β: 0.114 (0.0507) |
AUROC: 0.525 [0.496, 0.554] | Nagelkerke's Pseudo-R²: 0.00233 Brier score: 0.0827 Odds Ratio (OR, top 1% vs. Rest): 2.21 [1.08, 4.51] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_UKBB-SAIGE-HRC-X165.1_PT_MGI_20200608 |
| PPM001082 | PGS000397 (PRSWEB_PHECODE165.1_UKBB-SAIGE-HRC-X165.1_LASSOSUM_MGI_20200608) |
PSS000541| European Ancestry| 4,698 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of bronchus; lung | OR: 1.114 [1.009, 1.23] β: 0.108 (0.0507) |
AUROC: 0.528 [0.503, 0.556] | Nagelkerke's Pseudo-R²: 0.00202 Brier score: 0.0827 Odds Ratio (OR, top 1% vs. Rest): 1.03 [0.387, 2.77] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_UKBB-SAIGE-HRC-X165.1_LASSOSUM_MGI_20200608 |
| PPM008284 | PGS001109 (GBE_HC1021) |
PSS004069| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE vasomotor and allergic rhinitis | — | AUROC: 0.5683 [0.54473, 0.59188] | R²: 0.01206 Incremental AUROC (full-covars): 0.00409 PGS R2 (no covariates): 0.00275 PGS AUROC (no covariates): 0.53243 [0.50926, 0.55561] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008285 | PGS001109 (GBE_HC1021) |
PSS004070| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE vasomotor and allergic rhinitis | — | AUROC: 0.54528 [0.51116, 0.5794] | R²: 0.01457 Incremental AUROC (full-covars): 0.00387 PGS R2 (no covariates): 0.00105 PGS AUROC (no covariates): 0.51375 [0.47834, 0.54917] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008286 | PGS001109 (GBE_HC1021) |
PSS004071| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE vasomotor and allergic rhinitis | — | AUROC: 0.6003 [0.58786, 0.61273] | R²: 0.0217 Incremental AUROC (full-covars): 0.02658 PGS R2 (no covariates): 0.00981 PGS AUROC (no covariates): 0.56712 [0.55454, 0.57969] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008287 | PGS001109 (GBE_HC1021) |
PSS004072| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE vasomotor and allergic rhinitis | — | AUROC: 0.55379 [0.53392, 0.57366] | R²: 0.00762 Incremental AUROC (full-covars): 0.0079 PGS R2 (no covariates): 0.00254 PGS AUROC (no covariates): 0.53239 [0.51256, 0.55222] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008288 | PGS001109 (GBE_HC1021) |
PSS004073| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE vasomotor and allergic rhinitis | — | AUROC: 0.59854 [0.59138, 0.6057] | R²: 0.02303 Incremental AUROC (full-covars): 0.02878 PGS R2 (no covariates): 0.0118 PGS AUROC (no covariates): 0.56998 [0.56268, 0.57727] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008800 | PGS001259 (GBE_HC49) |
PSS004511| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Hayfever/allergic rhinitis | — | AUROC: 0.58821 [0.55886, 0.61757] | R²: 0.01784 Incremental AUROC (full-covars): -0.00253 PGS R2 (no covariates): 0.00082 PGS AUROC (no covariates): 0.51547 [0.48626, 0.54467] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008801 | PGS001259 (GBE_HC49) |
PSS004512| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Hayfever/allergic rhinitis | — | AUROC: 0.56313 [0.52505, 0.60122] | R²: 0.02281 Incremental AUROC (full-covars): 0.00075 PGS R2 (no covariates): 0.0011 PGS AUROC (no covariates): 0.52627 [0.48539, 0.56716] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008802 | PGS001259 (GBE_HC49) |
PSS004513| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Hayfever/allergic rhinitis | — | AUROC: 0.60641 [0.59175, 0.62107] | R²: 0.02043 Incremental AUROC (full-covars): 0.01519 PGS R2 (no covariates): 0.00564 PGS AUROC (no covariates): 0.55414 [0.53891, 0.56936] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008803 | PGS001259 (GBE_HC49) |
PSS004514| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Hayfever/allergic rhinitis | — | AUROC: 0.60093 [0.57427, 0.6276] | R²: 0.02041 Incremental AUROC (full-covars): 0.00631 PGS R2 (no covariates): 0.00266 PGS AUROC (no covariates): 0.54086 [0.51259, 0.56913] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008804 | PGS001259 (GBE_HC49) |
PSS004515| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Hayfever/allergic rhinitis | — | AUROC: 0.60078 [0.59218, 0.60937] | R²: 0.02042 Incremental AUROC (full-covars): 0.01922 PGS R2 (no covariates): 0.00737 PGS AUROC (no covariates): 0.5597 [0.55096, 0.56843] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009117 | PGS001326 (GBE_HC431) |
PSS004496| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Emphysema | — | AUROC: 0.79508 [0.66687, 0.92329] | R²: 0.11615 Incremental AUROC (full-covars): -0.00299 PGS R2 (no covariates): 6e-05 PGS AUROC (no covariates): 0.54363 [0.35853, 0.72873] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009118 | PGS001326 (GBE_HC431) |
PSS004497| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Emphysema | — | AUROC: 0.98854 [0.98287, 0.99422] | R²: 0.35967 Incremental AUROC (full-covars): 0.00059 PGS R2 (no covariates): 0.01376 PGS AUROC (no covariates): 0.67098 [0.43987, 0.90208] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009119 | PGS001326 (GBE_HC431) |
PSS004498| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Emphysema | — | AUROC: 0.7867 [0.75313, 0.82026] | R²: 0.09488 Incremental AUROC (full-covars): -0.00065 PGS R2 (no covariates): 0.0 PGS AUROC (no covariates): 0.49994 [0.45601, 0.54388] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009120 | PGS001326 (GBE_HC431) |
PSS004499| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Emphysema | — | AUROC: 0.78275 [0.67463, 0.89087] | R²: 0.0813 Incremental AUROC (full-covars): 0.00398 PGS R2 (no covariates): 0.00648 PGS AUROC (no covariates): 0.59809 [0.42688, 0.7693] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009121 | PGS001326 (GBE_HC431) |
PSS004500| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Emphysema | — | AUROC: 0.72797 [0.70437, 0.75156] | R²: 0.05838 Incremental AUROC (full-covars): 0.00547 PGS R2 (no covariates): 0.00531 PGS AUROC (no covariates): 0.56911 [0.54137, 0.59684] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009146 | PGS001332 (GBE_HC442) |
PSS004506| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Chronic obstructive airways disease/copd | — | AUROC: 0.75825 [0.69744, 0.81905] | R²: 0.08985 Incremental AUROC (full-covars): 0.00297 PGS R2 (no covariates): 0.00366 PGS AUROC (no covariates): 0.56943 [0.4939, 0.64496] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009147 | PGS001332 (GBE_HC442) |
PSS004507| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Chronic obstructive airways disease/copd | — | AUROC: 0.93404 [0.85456, 1.0] | R²: 0.35918 Incremental AUROC (full-covars): 0.00775 PGS R2 (no covariates): 0.05713 PGS AUROC (no covariates): 0.78102 [0.65685, 0.90519] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009148 | PGS001332 (GBE_HC442) |
PSS004508| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Chronic obstructive airways disease/copd | — | AUROC: 0.75808 [0.74076, 0.77539] | R²: 0.10489 Incremental AUROC (full-covars): 0.0013 PGS R2 (no covariates): 0.00194 PGS AUROC (no covariates): 0.53674 [0.51446, 0.55902] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009149 | PGS001332 (GBE_HC442) |
PSS004509| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Chronic obstructive airways disease/copd | — | AUROC: 0.74266 [0.70089, 0.78443] | R²: 0.08552 Incremental AUROC (full-covars): -0.00028 PGS R2 (no covariates): 0.00048 PGS AUROC (no covariates): 0.51815 [0.46516, 0.57113] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009150 | PGS001332 (GBE_HC442) |
PSS004510| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Chronic obstructive airways disease/copd | — | AUROC: 0.73063 [0.71971, 0.74156] | R²: 0.08401 Incremental AUROC (full-covars): 0.003 PGS R2 (no covariates): 0.00235 PGS AUROC (no covariates): 0.53971 [0.52633, 0.5531] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009151 | PGS001333 (GBE_HC1582) |
PSS004297| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: AD chronic obstructive pulmonary disease | — | AUROC: 0.68968 [0.6281, 0.75125] | R²: 0.05389 Incremental AUROC (full-covars): -0.00542 PGS R2 (no covariates): 5e-05 PGS AUROC (no covariates): 0.49374 [0.43492, 0.55257] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009152 | PGS001333 (GBE_HC1582) |
PSS004298| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: AD chronic obstructive pulmonary disease | — | AUROC: 0.77182 [0.67988, 0.86376] | R²: 0.12635 Incremental AUROC (full-covars): -0.00429 PGS R2 (no covariates): 0.00238 PGS AUROC (no covariates): 0.55811 [0.43123, 0.68498] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009153 | PGS001333 (GBE_HC1582) |
PSS004299| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: AD chronic obstructive pulmonary disease | — | AUROC: 0.71622 [0.70023, 0.7322] | R²: 0.08141 Incremental AUROC (full-covars): 0.00289 PGS R2 (no covariates): 0.00236 PGS AUROC (no covariates): 0.53939 [0.52155, 0.55723] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009154 | PGS001333 (GBE_HC1582) |
PSS004300| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: AD chronic obstructive pulmonary disease | — | AUROC: 0.71121 [0.67474, 0.74767] | R²: 0.06785 Incremental AUROC (full-covars): 0.00468 PGS R2 (no covariates): 0.00251 PGS AUROC (no covariates): 0.53996 [0.49615, 0.58377] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009155 | PGS001333 (GBE_HC1582) |
PSS004301| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: AD chronic obstructive pulmonary disease | — | AUROC: 0.70059 [0.69045, 0.71072] | R²: 0.06924 Incremental AUROC (full-covars): 0.0031 PGS R2 (no covariates): 0.00218 PGS AUROC (no covariates): 0.5364 [0.52484, 0.54796] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009156 | PGS001334 (GBE_HC1035) |
PSS004079| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other chronic obstructive pulmonary disease | — | AUROC: 0.75968 [0.69978, 0.81959] | R²: 0.09174 Incremental AUROC (full-covars): -0.0023 PGS R2 (no covariates): 0.00029 PGS AUROC (no covariates): 0.4865 [0.41003, 0.56298] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009157 | PGS001334 (GBE_HC1035) |
PSS004080| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other chronic obstructive pulmonary disease | — | AUROC: 0.92777 [0.86245, 0.9931] | R²: 0.33262 Incremental AUROC (full-covars): 0.00135 PGS R2 (no covariates): 0.00048 PGS AUROC (no covariates): 0.52185 [0.32406, 0.71963] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009158 | PGS001334 (GBE_HC1035) |
PSS004081| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other chronic obstructive pulmonary disease | — | AUROC: 0.75602 [0.73955, 0.77249] | R²: 0.10564 Incremental AUROC (full-covars): 0.00136 PGS R2 (no covariates): 0.00195 PGS AUROC (no covariates): 0.53598 [0.51506, 0.55689] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009159 | PGS001334 (GBE_HC1035) |
PSS004082| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other chronic obstructive pulmonary disease | — | AUROC: 0.74851 [0.70987, 0.78716] | R²: 0.09156 Incremental AUROC (full-covars): 0.00157 PGS R2 (no covariates): 0.00202 PGS AUROC (no covariates): 0.53954 [0.49035, 0.58873] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009160 | PGS001334 (GBE_HC1035) |
PSS004083| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE other chronic obstructive pulmonary disease | — | AUROC: 0.72542 [0.71492, 0.73591] | R²: 0.0827 Incremental AUROC (full-covars): 0.00368 PGS R2 (no covariates): 0.00314 PGS AUROC (no covariates): 0.54658 [0.5339, 0.55926] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM009312 | PGS001783 (1kgeur_gbmi_COPD_pst_eff_a1_b0.5_phiauto) |
PSS007694| European Ancestry| 7,128 individuals |
PGP000262 | Wang Y et al. Cell Genom (2023) |
Reported Trait: Chronic obstructive pulmonary disease | — | AUROC: 0.74 | Nagelkerke's R2 (covariates regressed out): 0.03809 | sex,age, 20PCs | — |
| PPM009292 | PGS001788 (1kgeur_gbmi_leaveUKBBout_COPD_pst_eff_a1_b0.5_phiauto) |
PSS007711| European Ancestry| 337,168 individuals |
PGP000262 | Wang Y et al. Cell Genom (2023) |
Reported Trait: Chronic obstructive pulmonary disease | — | AUROC: 0.715 | Nagelkerke's R2 (covariates regressed out): 0.0163 | sex,age,age2,age*sex,age^2*sex, 20PCs | — |
| PPM009690 | PGS001850 (portability-PLR_496) |
PSS009325| European Ancestry| 18,735 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.0241 [0.0098, 0.0384] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009691 | PGS001850 (portability-PLR_496) |
PSS009099| European Ancestry| 3,959 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.0029 [-0.0284, 0.0341] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009692 | PGS001850 (portability-PLR_496) |
PSS008653| European Ancestry| 6,311 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.0292 [0.0045, 0.0539] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009694 | PGS001850 (portability-PLR_496) |
PSS008207| South Asian Ancestry| 5,753 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): -0.0056 [-0.0315, 0.0203] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009697 | PGS001850 (portability-PLR_496) |
PSS008876| African Ancestry| 3,652 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): -0.0066 [-0.0391, 0.0259] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009693 | PGS001850 (portability-PLR_496) |
PSS008427| Greater Middle Eastern Ancestry| 1,122 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.0083 [-0.0508, 0.0673] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009695 | PGS001850 (portability-PLR_496) |
PSS007989| East Asian Ancestry| 1,729 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): -0.017 [-0.0644, 0.0304] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009696 | PGS001850 (portability-PLR_496) |
PSS007772| African Ancestry| 2,270 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.0156 [-0.0258, 0.0569] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM011359 | PGS002062 (portability-ldpred2_496) |
PSS009099| European Ancestry| 3,959 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.0118 [-0.0194, 0.043] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM011360 | PGS002062 (portability-ldpred2_496) |
PSS008653| European Ancestry| 6,311 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.0499 [0.0252, 0.0745] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM011361 | PGS002062 (portability-ldpred2_496) |
PSS008427| Greater Middle Eastern Ancestry| 1,122 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.0345 [-0.0246, 0.0933] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM011362 | PGS002062 (portability-ldpred2_496) |
PSS008207| South Asian Ancestry| 5,753 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.0272 [0.0013, 0.053] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM011363 | PGS002062 (portability-ldpred2_496) |
PSS007989| East Asian Ancestry| 1,729 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): -0.0227 [-0.07, 0.0248] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM011364 | PGS002062 (portability-ldpred2_496) |
PSS007772| African Ancestry| 2,270 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.0422 | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM011365 | PGS002062 (portability-ldpred2_496) |
PSS008876| African Ancestry| 3,652 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): -0.0266 [-0.0591, 0.0059] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM011358 | PGS002062 (portability-ldpred2_496) |
PSS009325| European Ancestry| 18,735 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Chronic airway obstruction | — | — | Partial Correlation (partial-r): 0.047 [0.0327, 0.0613] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM013010 | PGS002291 (PRS12_NPC) |
PSS009646| East Asian Ancestry| 2,893 individuals |
PGP000320 | He YQ et al. Nat Commun (2022) |
Reported Trait: Nasopharyngeal carcinoma | — | AUROC: 0.64 | — | — | — |
| PPM013011 | PGS002291 (PRS12_NPC) |
PSS009646| East Asian Ancestry| 2,893 individuals |
PGP000320 | He YQ et al. Nat Commun (2022) |
Reported Trait: Nasopharyngeal carcinoma | — | AUROC: 0.69 | — | Family history of NPC | — |
| PPM022453 | PGS002291 (PRS12_NPC) |
PSS011948| East Asian Ancestry| 4,804 individuals |
PGP000714 | Diao H et al. J Med Virol (2023) |Ext. |
Reported Trait: Nasopharyngeal carcinoma | — | — | Odds ratio (OR, high vs low tertile): 2.57 [2.28, 2.9] | — | — |
| PPM022454 | PGS002291 (PRS12_NPC) |
PSS011948| East Asian Ancestry| 4,804 individuals |
PGP000714 | Diao H et al. J Med Virol (2023) |Ext. |
Reported Trait: Nasopharyngeal carcinoma x VCA-IgA interaction | — | — | Odds ratio (OR, positive VCA-IgA and high PRS vs. negative VCA-IgA and low PRS): 257.96 [178.2, 386.23] Synergy index (SI): 3.1 [2.17, 4.44] |
— | — |
| PPM020580 | PGS004465 (disease.J33.score) |
PSS011364| European Ancestry| 56,192 individuals |
PGP000561 | Jung H et al. Commun Biol (2024) |
Reported Trait: J33 (Nasal polyp) | OR: 1.3496 | — | — | — | — |
| PPM020581 | PGS004466 (disease.J44.score) |
PSS011364| European Ancestry| 56,192 individuals |
PGP000561 | Jung H et al. Commun Biol (2024) |
Reported Trait: J44 (Other chronic obstructive pulmonary disease) | OR: 1.30839 | — | — | — | — |
| PPM020650 | PGS004535 (meta.J33.score) |
PSS011364| European Ancestry| 56,192 individuals |
PGP000561 | Jung H et al. Commun Biol (2024) |
Reported Trait: J33 (Nasal polyp) | OR: 1.60067 | — | — | — | — |
| PPM020651 | PGS004536 (meta.J44.score) |
PSS011364| European Ancestry| 56,192 individuals |
PGP000561 | Jung H et al. Commun Biol (2024) |
Reported Trait: J44 (Other chronic obstructive pulmonary disease) | OR: 1.48758 | — | — | — | — |
| PPM030710 | PGS012564 (GRS22_COPD) |
PSS012261| European Ancestry| 277,059 individuals |
PGP000808 | Li J et al. BMC Med (2024) |
Reported Trait: Incident COPD | HR: 1.09 [1.06, 1.12] | — | — | age, sex, and the first 10 principal components of ancestry | — |
| PPM030711 | PGS012564 (GRS22_COPD) |
PSS012261| European Ancestry| 277,059 individuals |
PGP000808 | Li J et al. BMC Med (2024) |
Reported Trait: Incident COPD x current work schedule interaction | — | — | Hazard ratio (HR, usual/permanent night shift and high PRS vs. day workers and low PRS): 1.9 [1.63, 2.22] | age, sex, BMI, Townsend deprivation index, sleep duration, smoking status, alcohol drinking, IPAQ activity group, chronotype, asthma | — |
| PPM036647 | PGS018465 (TPMI_149_Lassosum2) |
PSS012373| East Asian Ancestry| 19,194 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of larynx pharynx nasal cavities | — | AUROC: 0.72273 | R²: 0.03266 | sex, age, array, PCs 1-10 | — |
| PPM036648 | PGS018466 (TPMI_149_LDpred2) |
PSS012372| East Asian Ancestry| 19,194 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of larynx pharynx nasal cavities | — | AUROC: 0.72128 | R²: 0.03204 | sex, age, array, PCs 1-10 | — |
| PPM036649 | PGS018467 (TPMI_149_MegaPRS) |
PSS012374| East Asian Ancestry| 19,194 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of larynx pharynx nasal cavities | — | AUROC: 0.7201 | R²: 0.03195 | sex, age, array, PCs 1-10 | — |
| PPM036650 | PGS018468 (TPMI_149_PRS-CS) |
PSS012375| East Asian Ancestry| 19,194 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of larynx pharynx nasal cavities | — | AUROC: 0.71945 | R²: 0.03162 | sex, age, array, PCs 1-10 | — |
| PPM036651 | PGS018469 (TPMI_149_SBayesR) |
PSS012376| East Asian Ancestry| 19,194 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of larynx pharynx nasal cavities | — | AUROC: 0.71838 | R²: 0.03124 | sex, age, array, PCs 1-10 | — |
| PPM036652 | PGS018470 (TPMI_149.2_Lassosum2) |
PSS012368| East Asian Ancestry| 19,070 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of nasopharynx | — | AUROC: 0.7073 | R²: 0.01637 | sex, age, array, PCs 1-10 | — |
| PPM036653 | PGS018471 (TPMI_149.2_LDpred2) |
PSS012367| East Asian Ancestry| 19,070 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of nasopharynx | — | AUROC: 0.71186 | R²: 0.01717 | sex, age, array, PCs 1-10 | — |
| PPM036654 | PGS018472 (TPMI_149.2_MegaPRS) |
PSS012369| East Asian Ancestry| 19,070 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of nasopharynx | — | AUROC: 0.69527 | R²: 0.01463 | sex, age, array, PCs 1-10 | — |
| PPM036655 | PGS018473 (TPMI_149.2_PRS-CS) |
PSS012370| East Asian Ancestry| 19,070 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of nasopharynx | — | AUROC: 0.70955 | R²: 0.0161 | sex, age, array, PCs 1-10 | — |
| PPM036656 | PGS018474 (TPMI_149.2_SBayesR) |
PSS012371| East Asian Ancestry| 19,070 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of nasopharynx | — | AUROC: 0.69866 | R²: 0.01489 | sex, age, array, PCs 1-10 | — |
| PPM037447 | PGS019265 (TPMI_472_Lassosum2) |
PSS013168| East Asian Ancestry| 15,996 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Chronic pharyngitis and nasopharyngitis | — | AUROC: 0.65457 | R²: 0.07566 | sex, age, array, PCs 1-10 | — |
| PPM037448 | PGS019266 (TPMI_472_LDpred2) |
PSS013167| East Asian Ancestry| 15,996 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Chronic pharyngitis and nasopharyngitis | — | AUROC: 0.65289 | R²: 0.07467 | sex, age, array, PCs 1-10 | — |
| PPM037449 | PGS019267 (TPMI_472_MegaPRS) |
PSS013169| East Asian Ancestry| 15,996 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Chronic pharyngitis and nasopharyngitis | — | AUROC: 0.65281 | R²: 0.07434 | sex, age, array, PCs 1-10 | — |
| PPM037450 | PGS019268 (TPMI_472_PRS-CS) |
PSS013170| East Asian Ancestry| 15,996 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Chronic pharyngitis and nasopharyngitis | — | AUROC: 0.65155 | R²: 0.07394 | sex, age, array, PCs 1-10 | — |
| PPM037451 | PGS019269 (TPMI_472_SBayesR) |
PSS013171| East Asian Ancestry| 15,996 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Chronic pharyngitis and nasopharyngitis | — | AUROC: 0.65286 | R²: 0.07462 | sex, age, array, PCs 1-10 | — |
| PPM037457 | PGS019275 (TPMI_476_Lassosum2) |
PSS013178| East Asian Ancestry| 17,583 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Allergic rhinitis | — | AUROC: 0.66159 | R²: 0.1223 | sex, age, array, PCs 1-10 | — |
| PPM037458 | PGS019276 (TPMI_476_LDpred2) |
PSS013177| East Asian Ancestry| 17,583 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Allergic rhinitis | — | AUROC: 0.66228 | R²: 0.12353 | sex, age, array, PCs 1-10 | — |
| PPM037459 | PGS019277 (TPMI_476_MegaPRS) |
PSS013179| East Asian Ancestry| 17,583 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Allergic rhinitis | — | AUROC: 0.66233 | R²: 0.12293 | sex, age, array, PCs 1-10 | — |
| PPM037460 | PGS019278 (TPMI_476_PRS-CS) |
PSS013180| East Asian Ancestry| 17,583 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Allergic rhinitis | — | AUROC: 0.66181 | R²: 0.12306 | sex, age, array, PCs 1-10 | — |
| PPM037461 | PGS019279 (TPMI_476_SBayesR) |
PSS013181| East Asian Ancestry| 17,583 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Allergic rhinitis | — | AUROC: 0.66246 | R²: 0.12377 | sex, age, array, PCs 1-10 | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS013181 | 477,J30 | — | [ ,
45.95 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS008653 | — | — | 6,311 individuals | — | European | Italy (South Europe) | UKB | — |
| PSS000566 | PheCode:165.1; ICD9:162, 162.0, 162.2, 162.3, 162.4, 162.5, 162.8, 162.9, 231.2; ICD10:C33, C34.0, C34.1, C34.2, C34.3, C34.8, C34.9, D02.2 | — | [
|
— | European | — | UKB | — |
| PSS004297 | — | — | [
|
— | African unspecified | — | UKB | — |
| PSS004298 | — | — | [
|
— | East Asian | — | UKB | — |
| PSS004299 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
| PSS004300 | — | — | [
|
— | South Asian | — | UKB | — |
| PSS004301 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
| PSS007772 | — | — | 2,270 individuals | — | African American or Afro-Caribbean | Carribean | UKB | — |
| PSS008427 | — | — | 1,122 individuals | — | Greater Middle Eastern (Middle Eastern, North African or Persian) | Iran (Middle East) | UKB | — |
| PSS004069 | — | — | [
|
— | African unspecified | — | UKB | — |
| PSS004070 | — | — | [
|
— | East Asian | — | UKB | — |
| PSS004071 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
| PSS004072 | — | — | [
|
— | South Asian | — | UKB | — |
| PSS004073 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
| PSS009325 | — | — | 18,735 individuals | — | European | UK (+ Ireland) | UKB | — |
| PSS011948 | — | — | [
|
— | East Asian | — | EPI-NPC-2005, NPCGEE | — |
| PSS004079 | — | — | [
|
— | African unspecified | — | UKB | — |
| PSS004080 | — | — | [
|
— | East Asian | — | UKB | — |
| PSS004081 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
| PSS004082 | — | — | [
|
— | South Asian | — | UKB | — |
| PSS004083 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
| PSS007694 | — | — | [
|
— | European | — | CanPath | — |
| PSS012369 | 147,C11 | — | [ ,
45.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012370 | 147,C11 | — | [ ,
45.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012371 | 147,C11 | — | [ ,
45.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS009646 | — | — | [
|
— | East Asian | — | NR | — |
| PSS009099 | — | — | 3,959 individuals | — | European | Poland (NE Europe) | UKB | — |
| PSS012376 | 146, 147, 148, 149, 160, 161, 231.0, V10.02, V10.21, V10.22,C09, C10, C11, C12, C13, C14, C30.0, C30.1, C31, C32, D02.0 | — | [ ,
45.45 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS007711 | — | — | [
|
— | European | — | UKB | — |
| PSS008207 | — | — | 5,753 individuals | — | South Asian | India (South Asia) | UKB | — |
| PSS012367 | 147,C11 | — | [ ,
45.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012368 | 147,C11 | — | [ ,
45.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS004496 | — | — | [
|
— | African unspecified | — | UKB | — |
| PSS004497 | — | — | [
|
— | East Asian | — | UKB | — |
| PSS004498 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
| PSS004499 | — | — | [
|
— | South Asian | — | UKB | — |
| PSS004500 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
| PSS012373 | 146, 147, 148, 149, 160, 161, 231.0, V10.02, V10.21, V10.22,C09, C10, C11, C12, C13, C14, C30.0, C30.1, C31, C32, D02.0 | — | [ ,
45.45 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012372 | 146, 147, 148, 149, 160, 161, 231.0, V10.02, V10.21, V10.22,C09, C10, C11, C12, C13, C14, C30.0, C30.1, C31, C32, D02.0 | — | [ ,
45.45 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS011364 | — | — | 56,192 individuals | — | European | — | UKB | — |
| PSS012374 | 146, 147, 148, 149, 160, 161, 231.0, V10.02, V10.21, V10.22,C09, C10, C11, C12, C13, C14, C30.0, C30.1, C31, C32, D02.0 | — | [ ,
45.45 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012375 | 146, 147, 148, 149, 160, 161, 231.0, V10.02, V10.21, V10.22,C09, C10, C11, C12, C13, C14, C30.0, C30.1, C31, C32, D02.0 | — | [ ,
45.45 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS004506 | — | — | [
|
— | African unspecified | — | UKB | — |
| PSS004507 | — | — | [
|
— | East Asian | — | UKB | — |
| PSS004508 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
| PSS004509 | — | — | [
|
— | South Asian | — | UKB | — |
| PSS004510 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
| PSS004511 | — | — | [
|
— | African unspecified | — | UKB | — |
| PSS004512 | — | — | [
|
— | East Asian | — | UKB | — |
| PSS004513 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
| PSS004514 | — | — | [
|
— | South Asian | — | UKB | — |
| PSS004515 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
| PSS008876 | — | — | 3,652 individuals | — | African unspecified | Nigeria (West Africa) | UKB | — |
| PSS012261 | — | — | 277,059 individuals, 48.03 % Male samples |
Mean = 52.71 years Sd = 7.08 years |
European | — | UKB | — |
| PSS000536 | PheCode:149.4; ICD9CM:161.0, 161.1, 161.2, 161.3, 161.8, 161.9, 231.0, V10.21; ICD10CM:C32, C32.0, C32.1, C32.2, C32.3, C32.8, C32.9, D02.0 | — | [
|
— | European | — | MGI | — |
| PSS007989 | — | — | 1,729 individuals | — | East Asian | China (East Asia) | UKB | — |
| PSS013167 | 472,J31 | — | [ ,
46.43 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS000541 | PheCode:165.1; ICD9CM:162.0, 162.2, 162.3, 162.4, 162.5, 162.8, 162.9, 209.21, 231.2, V10.11; ICD10CM:C33, C34, C34.0, C34.00, C34.01, C34.02, C34.1, C34.10, C34.11, C34.12, C34.2, C34.3, C34.30, C34.31, C34.32, C34.8, C34.80, C34.81, C34.82, C34.9, C34.90, C34.91, C34.92, C7A.090, D02.2, D02.20, D02.21, D02.22 | — | [
|
— | European | — | MGI | — |
| PSS013168 | 472,J31 | — | [ ,
46.43 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS013169 | 472,J31 | — | [ ,
46.43 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS013170 | 472,J31 | — | [ ,
46.43 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS013171 | 472,J31 | — | [ ,
46.43 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS011324 | — | — | [ ,
47.0 % Male samples |
Median = 65.0 years | European | — | MCRC | — |
| PSS013177 | 477,J30 | — | [ ,
45.95 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS013178 | 477,J30 | — | [ ,
45.95 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS013179 | 477,J30 | — | [ ,
45.95 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS013180 | 477,J30 | — | [ ,
45.95 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |